⌘K

Login Start Free

Home/Filings/4/0000899243-22-023985

4//SEC Filing

Vieser Jaime 4

Accession 0000899243-22-023985

CIK 0001107421other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:31 PM ET

Size

9.8 KB

Accession

0000899243-22-023985

Insider Transaction Report

Form 4

Period: 2022-06-22

Alaunos Therapeutics, Inc.TCRT

Director

Transactions

Award
Common Stock
2022-06-22+40,000→ 745,321 total
Award
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total
Exercise: $0.82Exp: 2032-06-21→ Common Stock (100,000 underlying)

Holdings

Common Stock
(indirect: By Children)
75,000
Common Stock
(indirect: By Children)
100,000
Common Stock
(indirect: By Children)
75,000
Common Stock
(indirect: By Children)
75,000

Footnotes (1)

[F1]The option vests in twelve equal monthly installments beginning on July 13, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1

filerCIK 0001846045

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 4:31 PM ET
Size: 9.8 KB

View on SEC.gov